(Q36861438)

16 August 2017

Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression (English)

1 reference

16 August 2017

Anderson C

1

1 reference

16 August 2017

Hrabovsky S

2

1 reference

16 August 2017

McKinley Y

3

1 reference

16 August 2017

Tubesing K

4

1 reference

16 August 2017

Tang HP

5

1 reference

16 August 2017

Dunbar R

6

1 reference

16 August 2017

Mukhtar H

7

1 reference

16 August 2017

Elmets CA

8

1 reference

16 August 2017

1 May 1997

1 reference

Photochemistry and Photobiology

16 August 2017

1 reference

16 August 2017

65

1 reference

16 August 2017

5

1 reference

16 August 2017

895-901

1 reference

Preclinical examination of first and second generation photosensitizers used in photodynamic therapy

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Photodynamic therapy in oncology: mechanisms and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Photodynamic Therapy of Spontaneous Cancers in Felines, Canines, and Snakes With Chloro-aluminium Sulfonated Phthalocyanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

C5a, Cutaneous Mast Cells, and Inflammation: In Vitro and In Vivo Studies in a Murine Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Involvement of singlet oxygen in chloroaluminum phthalocyanine tetrasulfonate-mediated photoenhancement of lipid peroxidation in rat epidermal microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.1997.TB01940.X

10.1111/J.1751-1097.1997.TB01940.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference